首页 > 最新文献

Journal of General and Family Medicine最新文献

英文 中文
Availability of primary care physicians and hepatocellular carcinoma-related mortality in the United States 美国初级保健医生的可用性与肝细胞癌相关死亡率
IF 1.6 Q3 Medicine Pub Date : 2024-02-21 DOI: 10.1002/jgf2.679
Daniyal Raza MD, Udhayvir Singh Grewal MD

Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer worldwide and majority cases are diagnosed at an intermediate or advanced stage. Per our analysis, greater availability of primary care physicians correlates with lower HCC-related mortality. Our results underscore the need for efforts to expand access to primary care among all populations, especially African Americans, to improve overall HCC-related outcomes.

肝细胞癌(HCC)是全球第五大癌症病因,大多数病例在确诊时已处于中晚期。根据我们的分析,更多的初级保健医生与更低的 HCC 相关死亡率相关。我们的研究结果突出表明,有必要努力扩大所有人群(尤其是非裔美国人)获得初级保健的机会,以改善与 HCC 相关的总体预后。
{"title":"Availability of primary care physicians and hepatocellular carcinoma-related mortality in the United States","authors":"Daniyal Raza MD,&nbsp;Udhayvir Singh Grewal MD","doi":"10.1002/jgf2.679","DOIUrl":"https://doi.org/10.1002/jgf2.679","url":null,"abstract":"<p>Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer worldwide and majority cases are diagnosed at an intermediate or advanced stage. Per our analysis, greater availability of primary care physicians correlates with lower HCC-related mortality. Our results underscore the need for efforts to expand access to primary care among all populations, especially African Americans, to improve overall HCC-related outcomes.\u0000 <figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure></p>","PeriodicalId":51861,"journal":{"name":"Journal of General and Family Medicine","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jgf2.679","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140104431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment interruption in hypertensive patients during the COVID-19 pandemic: An interrupted time series analysis using prescription data in Okayama, Japan COVID-19 大流行期间高血压患者中断治疗的情况:利用日本冈山的处方数据进行间断时间序列分析
IF 1.6 Q3 Medicine Pub Date : 2024-02-21 DOI: 10.1002/jgf2.678
Naoko Nakamura MD, MPH, Toshiharu Mitsuhashi MD, PhD, Naomi Matsumoto MD, PhD, Shunsaku Hayase BEc, Takashi Yorifuji MD, PhD

Background

The COVID-19 pandemic has impacted healthcare behaviors, leading to fewer pediatric visits in Japan and potentially fewer visits by adult patients. However, existing Japanese studies on treatment interruptions have generally relied on questionnaire-based methods. In this study, we assessed the impact of the pandemic on antihypertensive treatment interruption using real-world prescription data.

Methods

We conducted an interrupted time series analysis using the National Health Insurance Database in Okayama Prefecture, Japan. Participants included individuals aged 40–69 years with at least one antihypertensive prescription between 2018 and 2020. Treatment interruption was defined as a 3-month or longer gap in prescriptions after medication depletion. We used segmented Poisson regression with models unadjusted and adjusted for seasonality and over-dispersion to assess monthly treatment interruptions before and after Japan's April 2020 emergency.

Results

During the study period, 23.0% of 55,431 participants experienced treatment interruptions. Cyclical fluctuations in interruptions were observed. The crude analysis indicated a 1.2-fold increase in treatment interruptions following the pandemic; however, the adjusted models showed no significant changes. Even among higher-risk groups, such as women, younger adults, and those with shorter prescriptions, no significant alterations were observed.

Conclusion

We found no significant impact of the COVID-19 pandemic on antihypertensive treatment interruption in Okayama Prefecture. The less severe outbreak in the area or increased use of telemedicine and extended prescriptions may have contributed to treatment continuity. Further research is needed using a more stable and comprehensive database, broader regional data, and detailed prescription records to validate and extend our findings.

背景 COVID-19 大流行影响了医疗保健行为,导致日本儿科就诊人数减少,成年患者就诊人数也可能减少。然而,日本现有的有关治疗中断的研究通常依赖于基于问卷的方法。在本研究中,我们使用真实处方数据评估了大流行对降压治疗中断的影响。 方法 我们利用日本冈山县的国民健康保险数据库进行了中断时间序列分析。参与者包括年龄在 40-69 岁之间、在 2018 年至 2020 年期间至少开过一次降压药处方的个人。治疗中断的定义是药物用完后处方出现 3 个月或更长时间的间隔。我们使用了分段泊松回归模型,对季节性和过度分散进行了未调整和调整,以评估日本 2020 年 4 月紧急事件前后的每月治疗中断情况。 结果 在研究期间,55,431 名参与者中有 23.0% 的人中断过治疗。观察到中断治疗的周期性波动。粗略分析表明,大流行后中断治疗的人数增加了 1.2 倍;但调整后的模型显示没有显著变化。即使在女性、年轻成年人和处方较短的人等高风险群体中,也没有观察到明显的变化。 结论 我们发现 COVID-19 大流行对冈山县的降压治疗中断没有明显影响。该地区的疫情较轻,或更多地使用远程医疗和延长处方可能有助于保持治疗的连续性。还需要使用更稳定、更全面的数据库、更广泛的地区数据和详细的处方记录来进一步研究,以验证和扩展我们的发现。
{"title":"Treatment interruption in hypertensive patients during the COVID-19 pandemic: An interrupted time series analysis using prescription data in Okayama, Japan","authors":"Naoko Nakamura MD, MPH,&nbsp;Toshiharu Mitsuhashi MD, PhD,&nbsp;Naomi Matsumoto MD, PhD,&nbsp;Shunsaku Hayase BEc,&nbsp;Takashi Yorifuji MD, PhD","doi":"10.1002/jgf2.678","DOIUrl":"https://doi.org/10.1002/jgf2.678","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The COVID-19 pandemic has impacted healthcare behaviors, leading to fewer pediatric visits in Japan and potentially fewer visits by adult patients. However, existing Japanese studies on treatment interruptions have generally relied on questionnaire-based methods. In this study, we assessed the impact of the pandemic on antihypertensive treatment interruption using real-world prescription data.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted an interrupted time series analysis using the National Health Insurance Database in Okayama Prefecture, Japan. Participants included individuals aged 40–69 years with at least one antihypertensive prescription between 2018 and 2020. Treatment interruption was defined as a 3-month or longer gap in prescriptions after medication depletion. We used segmented Poisson regression with models unadjusted and adjusted for seasonality and over-dispersion to assess monthly treatment interruptions before and after Japan's April 2020 emergency.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>During the study period, 23.0% of 55,431 participants experienced treatment interruptions. Cyclical fluctuations in interruptions were observed. The crude analysis indicated a 1.2-fold increase in treatment interruptions following the pandemic; however, the adjusted models showed no significant changes. Even among higher-risk groups, such as women, younger adults, and those with shorter prescriptions, no significant alterations were observed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>We found no significant impact of the COVID-19 pandemic on antihypertensive treatment interruption in Okayama Prefecture. The less severe outbreak in the area or increased use of telemedicine and extended prescriptions may have contributed to treatment continuity. Further research is needed using a more stable and comprehensive database, broader regional data, and detailed prescription records to validate and extend our findings.</p>\u0000 </section>\u0000 </div>","PeriodicalId":51861,"journal":{"name":"Journal of General and Family Medicine","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jgf2.678","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140104429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Japanese Patient Engagement Promotion Training (J-PEPT): Learning course on the implementation strategy of patient engagement 日本患者参与促进培训(J-PEPT):关于患者参与实施战略的学习课程
IF 1.6 Q3 Medicine Pub Date : 2024-02-12 DOI: 10.1002/jgf2.665
Masaru Kurihara MD, Shintaro Kosaka MD, Yusuke Yasumoto MD, Akie Yamaguchi, Tomomi Yoshida, Ayako Iyasu, Hideyuki Kashiwagi MD, Toru Kimura, Kiichi Enomoto, Kiyomi Tanno PhD, Keiko Inoue, Yaeko Ishihara, Noriko Iwaya, Aoki Takuya MD, PhD

Since the end of the 20th century, patient safety has become a global issue.1 Although many patient safety measures (such as changing the behavior of healthcare providers) have been taken, the role of patients in safety measures has also become more important in recent years. Patient engagement (PE) is defined as patients, families, their representatives, and health professionals working in active partnerships at various levels across the healthcare system to improve health and healthcare.2 PE to address safety issues that cannot be resolved by healthcare providers alone is considered by policy makers and healthcare providers. However, in Japan, there are barriers to improving patient safety, and one of them is the emphasis on patient centeredness, including PE.1 Translating patient-centered safety measures including PE from theory to implementation is challenging, making it a global issue; thus, it is important to create learning courses where PE can be taught. Therefore, to promote the PE implementation strategies in primary care, which have traditionally emphasized patient centeredness, we report a Japanese Patient Engagement Promotion Training (J-PEPT) course developed by the Committee on Quality and Patient Safety of the Japan Primary Care Association.

J-PEPT aims to provide participants with the necessary knowledge and skills to implement PE strategies in healthcare settings. It is held about twice a year and has been attended by more than 60 people from across the country to date. Participants include physicians, nurses, pharmacists, as well as patients. PE has been also emphasized when planning, involving not only healthcare professionals (including physicians), but also patients, families, and social scientists from various fields. This is designed such that participants can learn while incorporating diverse opinions, deepening their understanding of the importance of PE.

J-PEPT covers many topics regarding PE, including sessions on implementing PE in primary care using the “guide to improving patient safety in primary care settings by engaging patients and families”,3 utilizing patient experiences, and exploring PE in telemedicine. Several measures have been taken to enhance J-PEPT's implementation in healthcare settings: first, interactive opportunities are provided to offer participants a chance to learn how to promote implementation in their respective healthcare settings. Second, a mindset that can serve as an implementation champion within healthcare institutions is conveyed. Finally, opportunities for patient input are always provided to participants to spark insights, treating the course itself as an opportunity for PE.

In each session, learning objectives are set, and a survey using a 5-point Likert scale (1: “strongly disagree” to 5: “strongly agree”) is conducted to assess whether these objectives have been achi

近年来,患者参与促进患者安全受到重视。因此,日本初级保健协会质量与患者安全委员会开发了日本患者参与促进培训(J-PEPT)课程。J-PEPT 促进了患者参与战略的实施,并有助于在全国范围内推广患者安全。
{"title":"Japanese Patient Engagement Promotion Training (J-PEPT): Learning course on the implementation strategy of patient engagement","authors":"Masaru Kurihara MD,&nbsp;Shintaro Kosaka MD,&nbsp;Yusuke Yasumoto MD,&nbsp;Akie Yamaguchi,&nbsp;Tomomi Yoshida,&nbsp;Ayako Iyasu,&nbsp;Hideyuki Kashiwagi MD,&nbsp;Toru Kimura,&nbsp;Kiichi Enomoto,&nbsp;Kiyomi Tanno PhD,&nbsp;Keiko Inoue,&nbsp;Yaeko Ishihara,&nbsp;Noriko Iwaya,&nbsp;Aoki Takuya MD, PhD","doi":"10.1002/jgf2.665","DOIUrl":"10.1002/jgf2.665","url":null,"abstract":"<p>Since the end of the 20th century, patient safety has become a global issue.<span><sup>1</sup></span> Although many patient safety measures (such as changing the behavior of healthcare providers) have been taken, the role of patients in safety measures has also become more important in recent years. Patient engagement (PE) is defined as patients, families, their representatives, and health professionals working in active partnerships at various levels across the healthcare system to improve health and healthcare.<span><sup>2</sup></span> PE to address safety issues that cannot be resolved by healthcare providers alone is considered by policy makers and healthcare providers. However, in Japan, there are barriers to improving patient safety, and one of them is the emphasis on patient centeredness, including PE.<span><sup>1</sup></span> Translating patient-centered safety measures including PE from theory to implementation is challenging, making it a global issue; thus, it is important to create learning courses where PE can be taught. Therefore, to promote the PE implementation strategies in primary care, which have traditionally emphasized patient centeredness, we report a Japanese Patient Engagement Promotion Training (J-PEPT) course developed by the Committee on Quality and Patient Safety of the Japan Primary Care Association.</p><p>J-PEPT aims to provide participants with the necessary knowledge and skills to implement PE strategies in healthcare settings. It is held about twice a year and has been attended by more than 60 people from across the country to date. Participants include physicians, nurses, pharmacists, as well as patients. PE has been also emphasized when planning, involving not only healthcare professionals (including physicians), but also patients, families, and social scientists from various fields. This is designed such that participants can learn while incorporating diverse opinions, deepening their understanding of the importance of PE.</p><p>J-PEPT covers many topics regarding PE, including sessions on implementing PE in primary care using the “guide to improving patient safety in primary care settings by engaging patients and families”,<span><sup>3</sup></span> utilizing patient experiences, and exploring PE in telemedicine. Several measures have been taken to enhance J-PEPT's implementation in healthcare settings: first, interactive opportunities are provided to offer participants a chance to learn how to promote implementation in their respective healthcare settings. Second, a mindset that can serve as an implementation champion within healthcare institutions is conveyed. Finally, opportunities for patient input are always provided to participants to spark insights, treating the course itself as an opportunity for PE.</p><p>In each session, learning objectives are set, and a survey using a 5-point Likert scale (1: “strongly disagree” to 5: “strongly agree”) is conducted to assess whether these objectives have been achi","PeriodicalId":51861,"journal":{"name":"Journal of General and Family Medicine","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jgf2.665","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139842495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author reply to the definition and evaluation of uncoordinated involvement of multiple healthcare providers; “Polydoctoring” as a component of care fragmentation among patients with multimorbidity 作者对多个医疗服务提供者不协调参与的定义和评估的答复;"多医生 "是多病症患者护理分散的一个组成部分
IF 1.6 Q3 Medicine Pub Date : 2024-01-31 DOI: 10.1002/jgf2.676
Takayuki Ando MD, MPH, Takashi Sasaki PhD, Yukiko Abe BA, Yoshinori Nishimoto MD, PhD, Takumi Hirata MD, MPH, PhD, Junji Haruta MD, PhD, Yasumichi Arai MD, PhD

We appreciate the opportunity to respond to the concerns raised in the letter1 regarding our article, “Measurement of polydoctoring as a crucial component of fragmentation of care among patients with multimorbidity: Cross-sectional study in Japan.”2

First, we acknowledge the point that in Japan, organ-specific specialists often undertake primary care. This indeed contributes to the prevalence of polydoctoring as patients navigate through multiple healthcare providers. We agree that this unique aspect of Japanese healthcare necessitates a more nuanced understanding of polydoctoring, particularly how it impacts patients with multimorbidity. The propensity for patients to consult multiple healthcare providers is an important aspect of our study, and it is evident that this practice has deep roots in the structural makeup of Japanese healthcare.

Interestingly, our data indicated that approximately one-third of the participants were engaged in regular relationships with a single institution even though they have multimorbidity. This subset of the study population presents an important contrast to the polydoctoring narrative and suggests the presence of integrated care pathways for some patients. This variation in care-seeking behavior offers a unique perspective on patient autonomy and the choices made in managing their health within the existing healthcare framework.

The definition of high-risk polydoctoring is a critical area for further research. The delineation between necessary multidisciplinary care and potentially detrimental polydoctoring remains ambiguous and is subject to individual patient circumstances. Our study's threshold for high-risk polydoctoring may warrant reevaluation in future research to establish more precise criteria that can reliably predict adverse outcomes. Furthermore, it is important to note that fragmentation of care is influenced not only by the number of healthcare providers involved but also by the quality of coordination among them. However, objectively assessing the quality of coordination among various healthcare professionals remains a significant challenge in the current landscape.3 Future research efforts should be directed toward developing methodologies to measure the quality of coordination of care, an aspect crucial for understanding and improving patient care.

Regarding the concerns about selection bias, the letter accurately identifies a significant limitation of our study. Our focus on independently living elderly individuals excluded patients receiving home-based medical care. This omits a crucial subset of patients who may be receiving the most comprehensive care, potentially skewing our understanding of polydoctoring in the broader spectrum of care delivery. The homebound patients, often with diminished physical function, represent a contrasting group to the ambulatory patients who were the focus of our s

我们很高兴有机会对来信1 中就我们的文章 "Measurement of polydoctoring as a crucial component of fragmentation of care among patients with multimorbidity:2首先,我们承认在日本,器官专科医生经常承担初级医疗服务。这确实导致了多科性的普遍存在,因为患者要在多个医疗服务提供者之间穿梭。我们同意,日本医疗保健的这一独特方面要求我们对多科性有更细致的了解,尤其是它对多病患者的影响。患者向多个医疗机构咨询的倾向是我们研究的一个重要方面,很明显,这种做法在日本医疗保健的结构构成中有着深厚的根基。有趣的是,我们的数据显示,约有三分之一的参与者与单一机构保持着固定的关系,即使他们患有多病。研究人群中的这部分人与 "多病医生 "的说法形成了鲜明对比,并表明部分患者存在综合医疗途径。这种寻求医疗服务的行为差异为我们提供了一个独特的视角,让我们了解患者的自主性以及他们在现有医疗保健框架内管理自身健康时所做出的选择。必要的多学科医疗与可能有害的多学科医疗之间的界限仍然模糊不清,并且受制于患者的个体情况。我们研究中的高风险多科性阈值可能需要在未来的研究中重新评估,以建立能可靠预测不良后果的更精确的标准。此外,值得注意的是,医疗服务的分散性不仅受到参与其中的医疗服务提供者数量的影响,还受到他们之间协调质量的影响。3 未来的研究工作应致力于开发衡量医疗协调质量的方法,这对于了解和改善患者护理至关重要。关于选择偏差的担忧,来信准确地指出了我们研究的一个重要局限。我们的研究重点是独立生活的老年人,不包括接受家庭医疗护理的患者。这就遗漏了一部分重要的患者,他们可能正在接受最全面的医疗服务,这可能会影响我们对更广泛的医疗服务中多点执业的理解。居家病人通常身体功能减退,与我们研究重点关注的非卧床病人形成鲜明对比。通过集中研究能够到门诊就诊的老年人,我们清楚地了解到在典型的初级保健环境中,与家庭医生和全科医生所诊治的大部分患者相关的多医生现象。我们认识到有必要继续开展研究,探索这一现象的细微差别及其对医疗结果的影响。您富有洞察力的意见为今后的研究提供了宝贵的参考,我们期待着为这一重要领域做出更大的贡献。TA 撰写了手稿,所有作者都对手稿进行了审阅和编辑。所有作者声明他们没有利益冲突需要披露。
{"title":"Author reply to the definition and evaluation of uncoordinated involvement of multiple healthcare providers; “Polydoctoring” as a component of care fragmentation among patients with multimorbidity","authors":"Takayuki Ando MD, MPH,&nbsp;Takashi Sasaki PhD,&nbsp;Yukiko Abe BA,&nbsp;Yoshinori Nishimoto MD, PhD,&nbsp;Takumi Hirata MD, MPH, PhD,&nbsp;Junji Haruta MD, PhD,&nbsp;Yasumichi Arai MD, PhD","doi":"10.1002/jgf2.676","DOIUrl":"https://doi.org/10.1002/jgf2.676","url":null,"abstract":"<p>We appreciate the opportunity to respond to the concerns raised in the letter<span><sup>1</sup></span> regarding our article, “Measurement of polydoctoring as a crucial component of fragmentation of care among patients with multimorbidity: Cross-sectional study in Japan.”<span><sup>2</sup></span></p><p>First, we acknowledge the point that in Japan, organ-specific specialists often undertake primary care. This indeed contributes to the prevalence of polydoctoring as patients navigate through multiple healthcare providers. We agree that this unique aspect of Japanese healthcare necessitates a more nuanced understanding of polydoctoring, particularly how it impacts patients with multimorbidity. The propensity for patients to consult multiple healthcare providers is an important aspect of our study, and it is evident that this practice has deep roots in the structural makeup of Japanese healthcare.</p><p>Interestingly, our data indicated that approximately one-third of the participants were engaged in regular relationships with a single institution even though they have multimorbidity. This subset of the study population presents an important contrast to the polydoctoring narrative and suggests the presence of integrated care pathways for some patients. This variation in care-seeking behavior offers a unique perspective on patient autonomy and the choices made in managing their health within the existing healthcare framework.</p><p>The definition of high-risk polydoctoring is a critical area for further research. The delineation between necessary multidisciplinary care and potentially detrimental polydoctoring remains ambiguous and is subject to individual patient circumstances. Our study's threshold for high-risk polydoctoring may warrant reevaluation in future research to establish more precise criteria that can reliably predict adverse outcomes. Furthermore, it is important to note that fragmentation of care is influenced not only by the number of healthcare providers involved but also by the quality of coordination among them. However, objectively assessing the quality of coordination among various healthcare professionals remains a significant challenge in the current landscape.<span><sup>3</sup></span> Future research efforts should be directed toward developing methodologies to measure the quality of coordination of care, an aspect crucial for understanding and improving patient care.</p><p>Regarding the concerns about selection bias, the letter accurately identifies a significant limitation of our study. Our focus on independently living elderly individuals excluded patients receiving home-based medical care. This omits a crucial subset of patients who may be receiving the most comprehensive care, potentially skewing our understanding of polydoctoring in the broader spectrum of care delivery. The homebound patients, often with diminished physical function, represent a contrasting group to the ambulatory patients who were the focus of our s","PeriodicalId":51861,"journal":{"name":"Journal of General and Family Medicine","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jgf2.676","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140104345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Residents' learning and behavior about tool-guided clinical assessment of social determinants of health 住院医师对以工具为指导的健康社会决定因素临床评估的学习和行为
IF 1.6 Q3 Medicine Pub Date : 2024-01-13 DOI: 10.1002/jgf2.674
Junki Mizumoto MD, Hirohisa Fujikawa MD, PhD, Masashi Izumiya MD, PhD, Shoko Horita MD, PhD, Masato Eto MD, PhD

Background

The specific dimensions of learners that have been impacted by educational programs related to social determinants of health (SDoH) remain unknown. This study aims to elucidate how learners are affected by postgraduate education (a single 90-min educational session) regarding tool-guided clinical assessment of patients' social backgrounds.

Methods

A pretest-posttest design was utilized in which residents (postgraduate year (PGY) 1 or 2) and fellows in family medicine (PGY over 3) were recruited. Likert-type questions were developed based on previous qualitative findings. Participants answered these questions before, immediately after, and 1.5 months after the educational session on tool-guided clinical SDoH assessment. Paired-sample t-tests were used, and effect size was measured using Cohen's d.

Results

A total of 114 residents and fellows participated. After the session, participants expressed more interest in knowing their patients' social backgrounds when considering how to address their patients and were more open to embracing a pre-established assessment framework. Participants also considered clinical skills related to SDoH as learnable and improved their attitude toward patients. They reported that they did not perform specific interventions related to SDoH within 1.5 months after the session. Unlike previous qualitative findings, their concern about the implementation of SDoH-related practices did not increase significantly.

Conclusion

An educational session on tool-guided SDoH assessment may have a positive impact on learners' attitudes related to addressing patients' social backgrounds without fostering concerns.

与健康的社会决定因素(SDoH)相关的教育项目对学习者的具体影响尚不清楚。本研究旨在阐明学习者如何受到研究生教育(单次 90 分钟的教育课程)的影响,即在工具指导下对患者的社会背景进行临床评估。本研究采用了前测-后测设计,招募了家庭医学专业的住院医师(研究生 1 年级或 2 年级)和研究员(研究生 3 年级以上)。根据以往的定性研究结果,设计了李克特(Likert)类型的问题。参加者在工具指导下进行临床 SDoH 评估的教育课程之前、之后和 1.5 个月之后回答了这些问题。共有 114 名住院医师和研究员参加了此次培训。课程结束后,参与者表示在考虑如何应对患者时,更有兴趣了解患者的社会背景,并更愿意接受预先建立的评估框架。参与者还认为与 SDoH 相关的临床技能是可以学习的,并改善了他们对患者的态度。他们表示,在课程结束后的 1.5 个月内,他们并没有采取与 SDoH 相关的具体干预措施。与以往的定性研究结果不同的是,他们对实施 SDoH 相关实践的担忧并没有显著增加。关于工具指导 SDoH 评估的教育课程可能会对学习者处理患者社会背景的态度产生积极影响,而不会引发担忧。
{"title":"Residents' learning and behavior about tool-guided clinical assessment of social determinants of health","authors":"Junki Mizumoto MD,&nbsp;Hirohisa Fujikawa MD, PhD,&nbsp;Masashi Izumiya MD, PhD,&nbsp;Shoko Horita MD, PhD,&nbsp;Masato Eto MD, PhD","doi":"10.1002/jgf2.674","DOIUrl":"10.1002/jgf2.674","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The specific dimensions of learners that have been impacted by educational programs related to social determinants of health (SDoH) remain unknown. This study aims to elucidate how learners are affected by postgraduate education (a single 90-min educational session) regarding tool-guided clinical assessment of patients' social backgrounds.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A pretest-posttest design was utilized in which residents (postgraduate year (PGY) 1 or 2) and fellows in family medicine (PGY over 3) were recruited. Likert-type questions were developed based on previous qualitative findings. Participants answered these questions before, immediately after, and 1.5 months after the educational session on tool-guided clinical SDoH assessment. Paired-sample <i>t</i>-tests were used, and effect size was measured using Cohen's <i>d</i>.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 114 residents and fellows participated. After the session, participants expressed more interest in knowing their patients' social backgrounds when considering how to address their patients and were more open to embracing a pre-established assessment framework. Participants also considered clinical skills related to SDoH as learnable and improved their attitude toward patients. They reported that they did not perform specific interventions related to SDoH within 1.5 months after the session. Unlike previous qualitative findings, their concern about the implementation of SDoH-related practices did not increase significantly.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>An educational session on tool-guided SDoH assessment may have a positive impact on learners' attitudes related to addressing patients' social backgrounds without fostering concerns.</p>\u0000 </section>\u0000 </div>","PeriodicalId":51861,"journal":{"name":"Journal of General and Family Medicine","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jgf2.674","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139531485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The definition and evaluation of uncoordinated involvement of multiple healthcare providers; “Polydoctoring” as a component of care fragmentation among patients which multimorbidity 对多个医疗服务提供者不协调参与的定义和评估;"多医生 "是多病症患者护理分散的一个组成部分
IF 1.6 Q3 Medicine Pub Date : 2024-01-13 DOI: 10.1002/jgf2.673
Yuki Ohnishi MD, Satoshi Watanuki MD

We read with great interest the article by T Ando et al, and appreciate the authors' efforts to assess the influence of the uncoordinated involvement of multiple healthcare providers: “polydoctoring.” The analysis highlights that the involvement of multiple healthcare facilities in patient care is correlated with a higher likelihood of polypharmacy and increased outpatient medical costs.1 However, we would like to point out two concerns.

First, a significant issue in this study was that using the definition of “polydoctoring,” which refers only to having two or more regularly visited facilities, cannot appropriately evaluate the current situation in Japan. It might be unavoidable for today's elderly individuals in Japan to visit multiple medical institutions more than two. Historically, organ specialists played an important role in primary care settings in Japan, and we still have approximately 100,000 primary clinics run by organ specialists. The Japan Primary Care Association (JPCA) has started a training program to qualify doctors as General Practitioner/Family Physician specialists since 2017.2 Although JPCA expects these doctors to address a wider variety of common problems such as eye problems and osteoporosis, as well as common medical conditions,3 it is inevitable to face a transient lack of genuine primary care physicians who have completed a proper program. Therefore, in Japan, visiting multiple clinics is necessary for elderly people with coexisting chronic conditions that are beyond the scope of the primary care physicians they see. While the primary care system in Japan is still in development, thanks to universal access under the national health insurance system, elderly individuals can visit multiple medical facilities and enjoy health equity. There is no doubt that the establishment of the universal health insurance scheme in 1961 supports freedom to access medical facilities and services in Japan.4 It might be effective to consider the medical specialties visited when renewing the definition of polydoctoring.

In addition, the sample selection was problematic. The authors enrolled individuals only from an independent-dwelling subset. Given the study result, if this survey were to include homebound elderly patients with multimorbidity, they would have fewer chances of receiving polypharmacy. Some elderly individuals, experiencing a decline in physical strength that makes it difficult to visit outpatient clinics, transition to home medical care, where their care should be consolidated. However, it was reported that the prevalence of inappropriate polypharmacy was 70% among older adults receiving home medical care.5 Inappropriate prescriptions do not always appear to be associated with care fragmentation.

Accordingly, we suggest that this study cannot accurately evaluate the impact of care fragm

我们饶有兴趣地阅读了 T Ando 等人的文章,并对作者努力评估多个医疗服务提供者不协调参与的影响表示赞赏:"多医生 "的影响。1 不过,我们想指出两点值得关注的问题。首先,这项研究中的一个重要问题是,使用 "多医生 "的定义(仅指有两个或两个以上定期就诊的医疗机构)并不能恰当地评估日本的现状。当今日本的老年人可能不可避免地要去两家以上的多家医疗机构就诊。历史上,器官专科医生在日本的初级医疗机构中发挥了重要作用,目前我们仍有约 10 万家由器官专科医生管理的初级诊所。日本初级保健协会(JPCA)从 2017 年开始启动了一项培训计划,旨在培养医生成为全科医师/家庭医生专家。2 虽然日本初级保健协会希望这些医生能够解决更广泛的常见问题,如眼部问题和骨质疏松症,以及常见的内科疾病,3 但不可避免地会面临暂时缺乏完成正规课程的真正初级保健医生的问题。因此,在日本,如果老年人同时患有慢性病,而这些慢性病又超出了初级保健医生的诊治范围,那么他们就必须去多家诊所就诊。虽然日本的初级保健系统仍在发展之中,但由于国民健康保险制度的普及,老年人可以到多家医疗机构就诊,享受健康公平。毫无疑问,1961 年建立的全民健康保险制度支持了日本医疗设施和服务的自由使用。4 在重新定义多科医生时,考虑就诊的医疗专科可能会更有效。此外,样本的选择也有问题,作者只从独立居住的人群中选取了一些人。从研究结果来看,如果这项调查将患有多种疾病的居家老年患者包括在内,他们接受多药治疗的机会就会减少。一些老人由于体力下降,难以到门诊就医,因此过渡到家庭医疗护理,在家庭医疗护理中,他们的护理应该得到加强。5 不恰当的处方似乎并不总是与护理分散相关。因此,我们认为,由于定义和样本选择的原因,本研究无法准确评估护理分散对患者预后的影响。要想了解多病患者的护理质量和效率,还需要进一步的研究。我们希望,通过解决医疗碎片化问题,日本的初级医疗能得到更大的改善。作者声明本文无利益冲突。
{"title":"The definition and evaluation of uncoordinated involvement of multiple healthcare providers; “Polydoctoring” as a component of care fragmentation among patients which multimorbidity","authors":"Yuki Ohnishi MD,&nbsp;Satoshi Watanuki MD","doi":"10.1002/jgf2.673","DOIUrl":"10.1002/jgf2.673","url":null,"abstract":"<p>We read with great interest the article by T Ando et al, and appreciate the authors' efforts to assess the influence of the uncoordinated involvement of multiple healthcare providers: “polydoctoring.” The analysis highlights that the involvement of multiple healthcare facilities in patient care is correlated with a higher likelihood of polypharmacy and increased outpatient medical costs.<span><sup>1</sup></span> However, we would like to point out two concerns.</p><p>First, a significant issue in this study was that using the definition of “polydoctoring,” which refers only to having two or more regularly visited facilities, cannot appropriately evaluate the current situation in Japan. It might be unavoidable for today's elderly individuals in Japan to visit multiple medical institutions more than two. Historically, organ specialists played an important role in primary care settings in Japan, and we still have approximately 100,000 primary clinics run by organ specialists. The Japan Primary Care Association (JPCA) has started a training program to qualify doctors as General Practitioner/Family Physician specialists since 2017.<span><sup>2</sup></span> Although JPCA expects these doctors to address a wider variety of common problems such as eye problems and osteoporosis, as well as common medical conditions,<span><sup>3</sup></span> it is inevitable to face a transient lack of genuine primary care physicians who have completed a proper program. Therefore, in Japan, visiting multiple clinics is necessary for elderly people with coexisting chronic conditions that are beyond the scope of the primary care physicians they see. While the primary care system in Japan is still in development, thanks to universal access under the national health insurance system, elderly individuals can visit multiple medical facilities and enjoy health equity. There is no doubt that the establishment of the universal health insurance scheme in 1961 supports freedom to access medical facilities and services in Japan.<span><sup>4</sup></span> It might be effective to consider the medical specialties visited when renewing the definition of polydoctoring.</p><p>In addition, the sample selection was problematic. The authors enrolled individuals only from an independent-dwelling subset. Given the study result, if this survey were to include homebound elderly patients with multimorbidity, they would have fewer chances of receiving polypharmacy. Some elderly individuals, experiencing a decline in physical strength that makes it difficult to visit outpatient clinics, transition to home medical care, where their care should be consolidated. However, it was reported that the prevalence of inappropriate polypharmacy was 70% among older adults receiving home medical care.<span><sup>5</sup></span> Inappropriate prescriptions do not always appear to be associated with care fragmentation.</p><p>Accordingly, we suggest that this study cannot accurately evaluate the impact of care fragm","PeriodicalId":51861,"journal":{"name":"Journal of General and Family Medicine","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jgf2.673","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139531242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A proposal for coping strategies on burnout among Japanese resident physicians 关于日本住院医生职业倦怠应对策略的建议
IF 1.6 Q3 Medicine Pub Date : 2023-12-26 DOI: 10.1002/jgf2.662
Kosuke Ishizuka MD, PhD, Kiyoshi Shikino MD, PhD, MHPE, FACP, Akira Kuriyama MD, MPH, PhD, Yoshito Nishimura MD, MPH, PhD, Emiri Tanaka MS, Saori Nonaka MD, Michito Sadohara MD, Mitsuru Moriya MD, PhD, Noriko Yamamoto MD, PhD, FACP, Yohnosuke Wada MD, MPH, Tetsuya Makiishi MD, PhD

To the Editor,

Burnout is a syndrome conceptualized by emotional exhaustion, depersonalization, and a diminished sense of personal achievement.1, 2 Physician burnout has several negative effects, including medical errors and mental ill health.2, 3 It is worth addressing that the prevalence of burnout among resident physicians in Japan is high at approximately 30%.4 Herein, we, the members of the American College of Physicians Japan Chapter Physicians' Well-being Committee, report factors contributing to burnout of Japanese resident physicians and propose specific countermeasures (Table 1). Our recommendations are the result of focus group discussions with individuals of broad expertise and recent evidence, ensuring that they are grounded and directly relevant to the current challenges faced by resident physicians in Japan.

Poor communication and stress in relationships with medical staff and patients may contribute to burnout among resident physicians.2, 3 Because most physicians in Japan start their careers without previous work experience, their communication skills with medical staff and patients may be underdeveloped. Mentoring, sharing plans within the medical team, and changing the teams may improve Communication with other medical staff. Resident physicians should also learn skills for coping with difficult patients who display strong negative feelings toward the physician.5 To cope with difficult patient encounters, metacognition of their own feelings, analysis on factors of difficult situations, and improvement in the capacity to empathize are important.5

Long working hours, increased workload, sleep deprivation owing to duty shifts, and increased burden of COVID-19 treatment are also risk factors for burnout.2, 3 Measures in line with the work reform of physicians in Japan, such as limiting or reducing work, introducing night flow, and mandatory rest after shifts, may be effective. Resilience can be improved by addressing “motivation” through coaching, setting incremental goals, building on successes to increase confidence, and setting new goals.1

In Japan, factors contributing to burnout among resident physicians include rotations through multiple departments and affiliated hospitals and changes in the environment, including community medicine and “tasuki-gake” training (clinical training in which resident physicians work alternately between primary hospitals and external hospitals/clinics on a 1 year basis). It may be important to limit the number of patients to be assigned at the beginning of the rotation and to simultaneously assess the resident physician's performance. In addition, although changes in the environment increase the number of tasks to be acquired, it is important to modify one's mindset, for exam

致编者:职业倦怠是一种综合征,其概念是情绪衰竭、人格解体和个人成就感降低、3 值得注意的是,日本住院医师的职业倦怠发生率很高,约为 30%。4 在此,我们美国内科医师学会日本分会医师福利委员会的成员报告了导致日本住院医师职业倦怠的因素,并提出了具体的对策(表 1)。我们的建议是与具有广泛专业知识和最新证据的个人进行焦点小组讨论的结果,确保这些建议有根有据,并与日本住院医师当前面临的挑战直接相关。与医务人员和患者沟通不畅、关系紧张可能会导致住院医师的职业倦怠。指导、在医疗团队内部分享计划以及改变团队可以改善与其他医务人员的沟通。住院医师还应该学习如何应对那些对医生表现出强烈负面情绪的难缠病人的技巧。5 要应对难缠病人,对自身感受的元认知、对困难情况因素的分析以及移情能力的提高都很重要。工作时间过长、工作量增加、轮班工作导致睡眠不足、COVID-19 治疗负担加重也是导致职业倦怠的风险因素。2, 3 与日本医生工作改革相一致的措施,如限制或减少工作时间、引入夜间流动、轮班后强制休息等,可能是有效的。1 在日本,导致住院医师职业倦怠的因素包括多个科室和附属医院的轮转以及环境的变化,包括社区医疗和 "tasuki-gake "培训(住院医师在基层医院和外部医院/诊所之间交替工作一年的临床培训)。在轮转开始时限制分配的病人数量并同时评估住院医师的表现可能很重要。此外,虽然环境的变化增加了需要掌握的任务数量,但重要的是要改变自己的心态,例如认识到掌握新技能的速度因人而异,并将环境变化视为职业发展的步骤。要解决工作满意度低的问题,重要的是通过辅导,关注工作中能提供自主性和乐趣的部分。1, 3 此外,重要的是创建一个平台,使临床住院医师能积极与同代人的榜样互动,以解决工作满意度低的问题。找出职业倦怠的原因并提供具体的对策,有助于预防住院医师的职业倦怠。应找出与住院医师职业倦怠相关的其他问题,并寻求减少其职业倦怠的干预措施。
{"title":"A proposal for coping strategies on burnout among Japanese resident physicians","authors":"Kosuke Ishizuka MD, PhD,&nbsp;Kiyoshi Shikino MD, PhD, MHPE, FACP,&nbsp;Akira Kuriyama MD, MPH, PhD,&nbsp;Yoshito Nishimura MD, MPH, PhD,&nbsp;Emiri Tanaka MS,&nbsp;Saori Nonaka MD,&nbsp;Michito Sadohara MD,&nbsp;Mitsuru Moriya MD, PhD,&nbsp;Noriko Yamamoto MD, PhD, FACP,&nbsp;Yohnosuke Wada MD, MPH,&nbsp;Tetsuya Makiishi MD, PhD","doi":"10.1002/jgf2.662","DOIUrl":"10.1002/jgf2.662","url":null,"abstract":"<p>To the Editor,</p><p>Burnout is a syndrome conceptualized by emotional exhaustion, depersonalization, and a diminished sense of personal achievement.<span><sup>1, 2</sup></span> Physician burnout has several negative effects, including medical errors and mental ill health.<span><sup>2, 3</sup></span> It is worth addressing that the prevalence of burnout among resident physicians in Japan is high at approximately 30%.<span><sup>4</sup></span> Herein, we, the members of the American College of Physicians Japan Chapter Physicians' Well-being Committee, report factors contributing to burnout of Japanese resident physicians and propose specific countermeasures (Table 1). Our recommendations are the result of focus group discussions with individuals of broad expertise and recent evidence, ensuring that they are grounded and directly relevant to the current challenges faced by resident physicians in Japan.</p><p>Poor communication and stress in relationships with medical staff and patients may contribute to burnout among resident physicians.<span><sup>2, 3</sup></span> Because most physicians in Japan start their careers without previous work experience, their communication skills with medical staff and patients may be underdeveloped. Mentoring, sharing plans within the medical team, and changing the teams may improve Communication with other medical staff. Resident physicians should also learn skills for coping with difficult patients who display strong negative feelings toward the physician.<span><sup>5</sup></span> To cope with difficult patient encounters, metacognition of their own feelings, analysis on factors of difficult situations, and improvement in the capacity to empathize are important.<span><sup>5</sup></span></p><p>Long working hours, increased workload, sleep deprivation owing to duty shifts, and increased burden of COVID-19 treatment are also risk factors for burnout.<span><sup>2, 3</sup></span> Measures in line with the work reform of physicians in Japan, such as limiting or reducing work, introducing night flow, and mandatory rest after shifts, may be effective. Resilience can be improved by addressing “motivation” through coaching, setting incremental goals, building on successes to increase confidence, and setting new goals.<span><sup>1</sup></span></p><p>In Japan, factors contributing to burnout among resident physicians include rotations through multiple departments and affiliated hospitals and changes in the environment, including community medicine and “<i>tasuki-gake</i>” training (clinical training in which resident physicians work alternately between primary hospitals and external hospitals/clinics on a 1 year basis). It may be important to limit the number of patients to be assigned at the beginning of the rotation and to simultaneously assess the resident physician's performance. In addition, although changes in the environment increase the number of tasks to be acquired, it is important to modify one's mindset, for exam","PeriodicalId":51861,"journal":{"name":"Journal of General and Family Medicine","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jgf2.662","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139156329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of long COVID complicated by postural orthostatic tachycardia syndrome—Case series research 长 COVID 并发体位性正位性心动过速综合征的治疗--病例系列研究
IF 1.6 Q3 Medicine Pub Date : 2023-12-18 DOI: 10.1002/jgf2.670
Tomoya Tsuchida MD, PhD, Yuki Ishibashi MD, PhD, Yoko Inoue MD, Kosuke Ishizuka MD, PhD, Kohta Katayama MD, PhD, Masanori Hirose MD, PhD, Yu Nakagama MD, PhD, Yasutoshi Kido MD, PhD, Yoshihiro Akashi MD, PhD, Takehito Otsubo MD, PhD, Takahide Matsuda MD, PhD, Yoshiyuki Ohira MD, PhD

Background

Coronavirus disease 2019 (COVID-19) sequelae, also known as long COVID, can present with various symptoms. Among these symptoms, autonomic dysregulation, particularly postural orthostatic tachycardia syndrome (POTS), should be evaluated. However, previous studies on the treatment of POTS complicated by COVID-19 are lacking. Therefore, this study aimed to investigate the treatment course of long COVID complicated by POTS.

Methods

The medical records of patients who complained of fatigue and met the criteria for POTS diagnosis were reviewed. We evaluated the treatment days, methods and changes in fatigue score, changes in heart rate on the Schellong test, and social situation at the first and last visits.

Results

Thirty-two patients with long COVID complicated by POTS were followed up (16 males; median age: 28 years). The follow-up period was 159 days, and the interval between COVID-19 onset and initial hospital attendance was 97 days. Some patients responded to β-blocker therapy. Many patients had psychiatric symptoms that required psychiatric intervention and selective serotonin reuptake inhibitor prescription. Changes in heart rate, performance status, and employment/education status improved from the first to the last visit. These outcomes were believed to be because of the effects of various treatment interventions and spontaneous improvements.

Conclusions

Our study suggests that the condition of 94% of patients with POTS complicated by long COVID will improve within 159 days. Therefore, POTS evaluation should be considered when patients with long COVID complain of fatigue, and attention should be paid to psychological symptoms and the social context.

冠状病毒病 2019(COVID-19)后遗症又称长COVID,可表现出各种症状。在这些症状中,自律神经失调,尤其是体位性正位性心动过速综合征(POTS),应予以评估。然而,以往缺乏关于治疗 COVID-19 并发的 POTS 的研究。因此,本研究旨在调查长 COVID 并发 POTS 的治疗过程。我们评估了首次和最后一次就诊时的治疗天数、方法和疲劳评分的变化、Schellong 试验心率的变化以及社会状况。32 名长 COVID 并发 POTS 患者接受了随访(16 名男性;中位年龄:28 岁)。随访时间为 159 天,COVID-19 发病与首次就诊之间的间隔时间为 97 天。一些患者对β受体阻滞剂治疗有反应。许多患者出现了精神症状,需要进行精神干预和服用选择性血清素再摄取抑制剂。从首次就诊到最后一次就诊,患者的心率、表现状况和就业/教育状况都有所改善。我们的研究表明,94% 的 POTS 并发长 COVID 患者的病情将在 159 天内得到改善。因此,当长COVID患者抱怨疲劳时,应考虑对POTS进行评估,并关注心理症状和社会环境。
{"title":"Treatment of long COVID complicated by postural orthostatic tachycardia syndrome—Case series research","authors":"Tomoya Tsuchida MD, PhD,&nbsp;Yuki Ishibashi MD, PhD,&nbsp;Yoko Inoue MD,&nbsp;Kosuke Ishizuka MD, PhD,&nbsp;Kohta Katayama MD, PhD,&nbsp;Masanori Hirose MD, PhD,&nbsp;Yu Nakagama MD, PhD,&nbsp;Yasutoshi Kido MD, PhD,&nbsp;Yoshihiro Akashi MD, PhD,&nbsp;Takehito Otsubo MD, PhD,&nbsp;Takahide Matsuda MD, PhD,&nbsp;Yoshiyuki Ohira MD, PhD","doi":"10.1002/jgf2.670","DOIUrl":"10.1002/jgf2.670","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Coronavirus disease 2019 (COVID-19) sequelae, also known as long COVID, can present with various symptoms. Among these symptoms, autonomic dysregulation, particularly postural orthostatic tachycardia syndrome (POTS), should be evaluated. However, previous studies on the treatment of POTS complicated by COVID-19 are lacking. Therefore, this study aimed to investigate the treatment course of long COVID complicated by POTS.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The medical records of patients who complained of fatigue and met the criteria for POTS diagnosis were reviewed. We evaluated the treatment days, methods and changes in fatigue score, changes in heart rate on the Schellong test, and social situation at the first and last visits.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Thirty-two patients with long COVID complicated by POTS were followed up (16 males; median age: 28 years). The follow-up period was 159 days, and the interval between COVID-19 onset and initial hospital attendance was 97 days. Some patients responded to β-blocker therapy. Many patients had psychiatric symptoms that required psychiatric intervention and selective serotonin reuptake inhibitor prescription. Changes in heart rate, performance status, and employment/education status improved from the first to the last visit. These outcomes were believed to be because of the effects of various treatment interventions and spontaneous improvements.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Our study suggests that the condition of 94% of patients with POTS complicated by long COVID will improve within 159 days. Therefore, POTS evaluation should be considered when patients with long COVID complain of fatigue, and attention should be paid to psychological symptoms and the social context.</p>\u0000 </section>\u0000 </div>","PeriodicalId":51861,"journal":{"name":"Journal of General and Family Medicine","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jgf2.670","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139175800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between mentorship and mental health among junior residents: A nationwide cross-sectional study in Japan 导师与初级住院医师心理健康之间的关系:日本全国横断面研究
IF 1.6 Q3 Medicine Pub Date : 2023-12-18 DOI: 10.1002/jgf2.671
Kohta Katayama MD, PhD, Yuji Nishizaki MD, MPH, PhD, Toshihiko Takada MD, MPH, MSc, PhD, Koshi Kataoka MMSc, Nathan Houchens MD, Takashi Watari MD, MHQS, MCTM, PhD, Yasuharu Tokuda MD, MPH, Yoshiyuki Ohira MD, PhD

Background

Mentorship is a dynamic, reciprocal relationship in which an advanced careerist (mentor) encourages the growth of a novice (mentee). Mentorship may protect the mental health of residents at risk for depression and burnout, yet despite its frequent use and known benefits, limited reports exist regarding the prevalence and mental effects of mentorship on residents in Japan.

Methods

We conducted a cross-sectional study involving postgraduate year 1 and 2 (PGY-1 and PGY-2) residents in Japan who took the General Medicine In-Training Examination (GM-ITE) at the end of the 2021 academic year. Data on mentorship were collected using surveys administered immediately following GM-ITE completion. The primary outcome was the Patient Health Questionaire-2 (PHQ-2), which consisted depressed mood and loss of interest. A positive response for either item indicated PHQ-2 positive. We examined associations between self-reported mentorship and PHQ-2 by multi-level analysis.

Results

Of 4929 residents, 3266 (66.3%) residents reported having at least one mentor. Compared to residents without any mentor, those with a mentor were associated with a lower likelihood of a positive PHQ-2 response (adjusted odds ratio [aOR] 0.75; 95% confidence interval [95% CI] 0.65–0.86). Mentor characteristic significantly associated with negative PHQ-2 response was a formal mentor (aOR; 0.68; 95% CI 0.55–0.84).

Conclusions

A mentor-based support system was positively associated with residents' mental health. Further research is needed to determine the quality of mentorship during clinical residency in Japan.

导师制是一种动态的互惠关系,在这种关系中,事业有成者(导师)鼓励新手(被指导者)成长。指导可以保护有抑郁和职业倦怠风险的住院医师的心理健康,然而,尽管指导被频繁使用且其益处众所周知,但有关指导在日本住院医师中的流行程度和心理影响的报告却很有限。我们进行了一项横断面研究,研究对象是在 2021 学年结束时参加全科医学在岗培训考试(GM-ITE)的日本研究生 1 年级和 2 年级(PGY-1 和 PGY-2)住院医师。通过在 GM-ITE 结束后立即进行的调查收集了有关导师指导的数据。主要结果是患者健康问卷-2(PHQ-2),包括情绪低落和失去兴趣。对其中任一项目的正面回答都表明 PHQ-2 呈阳性。在 4929 名住院医师中,有 3266 名(66.3%)住院医师表示至少有一名导师。与没有任何导师的住院医师相比,有导师的住院医师PHQ-2呈阳性反应的可能性较低(调整赔率[aOR]0.75;95%置信区间[95% CI]0.65-0.86)。与 PHQ-2 阴性反应明显相关的导师特征是正式导师(aOR; 0.68; 95% CI 0.55-0.84)。要确定日本临床住院医师指导的质量,还需要进一步的研究。
{"title":"Association between mentorship and mental health among junior residents: A nationwide cross-sectional study in Japan","authors":"Kohta Katayama MD, PhD,&nbsp;Yuji Nishizaki MD, MPH, PhD,&nbsp;Toshihiko Takada MD, MPH, MSc, PhD,&nbsp;Koshi Kataoka MMSc,&nbsp;Nathan Houchens MD,&nbsp;Takashi Watari MD, MHQS, MCTM, PhD,&nbsp;Yasuharu Tokuda MD, MPH,&nbsp;Yoshiyuki Ohira MD, PhD","doi":"10.1002/jgf2.671","DOIUrl":"10.1002/jgf2.671","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Mentorship is a dynamic, reciprocal relationship in which an advanced careerist (mentor) encourages the growth of a novice (mentee). Mentorship may protect the mental health of residents at risk for depression and burnout, yet despite its frequent use and known benefits, limited reports exist regarding the prevalence and mental effects of mentorship on residents in Japan.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a cross-sectional study involving postgraduate year 1 and 2 (PGY-1 and PGY-2) residents in Japan who took the General Medicine In-Training Examination (GM-ITE) at the end of the 2021 academic year. Data on mentorship were collected using surveys administered immediately following GM-ITE completion. The primary outcome was the Patient Health Questionaire-2 (PHQ-2), which consisted depressed mood and loss of interest. A positive response for either item indicated PHQ-2 positive. We examined associations between self-reported mentorship and PHQ-2 by multi-level analysis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of 4929 residents, 3266 (66.3%) residents reported having at least one mentor. Compared to residents without any mentor, those with a mentor were associated with a lower likelihood of a positive PHQ-2 response (adjusted odds ratio [aOR] 0.75; 95% confidence interval [95% CI] 0.65–0.86). Mentor characteristic significantly associated with negative PHQ-2 response was a formal mentor (aOR; 0.68; 95% CI 0.55–0.84).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>A mentor-based support system was positively associated with residents' mental health. Further research is needed to determine the quality of mentorship during clinical residency in Japan.</p>\u0000 </section>\u0000 </div>","PeriodicalId":51861,"journal":{"name":"Journal of General and Family Medicine","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jgf2.671","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138994668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Possible cause of abdominal internal oblique muscle hematoma induced by cough 咳嗽引起腹内斜肌血肿的可能原因
IF 1.6 Q3 Medicine Pub Date : 2023-12-18 DOI: 10.1002/jgf2.672
Toshinori Nishizawa MD

I have read with interest the article by Fujimori et al.1 This case involves a 40-year-old male patient who presented with an abdominal internal oblique muscle hematoma. The intriguing aspect of this case is that the hematoma occurred following a coughing episode, despite the absence of coagulation abnormalities.

Given this unique presentation, it is important to explore all possible underlying factors that could contribute to such an event. One potential cause is the presence of acquired hemophilia, specifically hemorrhagic acquired factor XIII deficiency.2 While the patient's platelet count and routine coagulation parameters might appear normal, it is crucial to emphasize that the absence of overt platelet or coagulation abnormalities does not definitively rule out the possibility of acquired factor XIII deficiency.

Acquired factor XIII deficiency is a relatively common disease, but most cases are asymptomatic and do not lead to severe bleeding. However, symptomatic acquired factor XIII deficiency, presenting with hemorrhagic symptoms, is exceedingly rare. This condition can be classified into autoimmune, nonautoimmune, and idiopathic types. Autoimmune acquired factor XIII deficiency is infrequent, with the majority of hemorrhagic acquired factor XIII deficiency being nonautoimmune. Nonautoimmune hemorrhagic acquired factor XIII deficiency, typically presenting as a less severe bleeding disorder, is often attributed to overconsumption or reduced biosynthesis. This can be triggered by various conditions, including disseminated intravascular coagulation, major surgical procedures, liver diseases, and other related disorders. In cases where acquired factor XIII deficiency is suspected, referral to a hematologist is advised, accompanied by a thorough investigation for any underlying pathologies.2

Since neither prolonged clotting times nor decreased platelet counts are seen, many cases with unexplained intramuscular and subcutaneous bleeding might be overlooked. However, depending on the site and the amount of bleeding, the bleeding can be fatal, so prompt diagnosis and appropriate treatment are essential. Clinicians should be alert for acquired factor XIII deficiency when seeing such patients and consider measuring the factor XIII activity.

In conclusion, I recommend further investigation into the possibility of acquired factor XIII deficiency in cases similar to the one described. The absence of overt platelet or coagulation abnormalities should not discourage the pursuit of this diagnostic avenue, as this disorder can present with severe bleeding.

The author declares no conflicts of interest for this article.

This work has never been presented.

我饶有兴趣地阅读了 Fujimori 等人的文章1。该病例涉及一名 40 岁的男性患者,他出现了腹内斜肌血肿。这个病例的耐人寻味之处在于,尽管没有凝血异常,但血肿是在咳嗽发作后发生的。鉴于这种独特的表现形式,探索可能导致此类事件的所有潜在因素非常重要。2 虽然患者的血小板计数和常规凝血指标可能看起来正常,但必须强调的是,没有明显的血小板或凝血异常并不能明确排除获得性因子 XIII 缺乏症的可能性。获得性因子 XIII 缺乏症是一种相对常见的疾病,但大多数病例没有症状,也不会导致严重出血。然而,无症状的获得性因子 XIII 缺乏症会出现出血症状,这种情况极为罕见。这种疾病可分为自身免疫、非自身免疫和特发性类型。自身免疫性获得性因子 XIII 缺乏症并不常见,大多数出血性获得性因子 XIII 缺乏症都是非自身免疫性的。非自身免疫性出血性获得性因子 XIII 缺乏症通常表现为不太严重的出血性疾病,通常归因于过度消耗或生物合成减少。引发这种情况的原因有很多,包括弥散性血管内凝血、大型外科手术、肝脏疾病和其他相关疾病。如果怀疑存在获得性 XIII 因子缺乏症,建议转诊至血液科医生,同时彻底检查是否存在潜在病变。2 由于凝血时间延长或血小板计数减少均不常见,许多不明原因的肌肉和皮下出血病例可能会被忽视。然而,根据出血部位和出血量的不同,出血可能是致命的,因此及时诊断和适当治疗至关重要。临床医生在接诊此类患者时应警惕获得性因子 XIII 缺乏症,并考虑测量因子 XIII 活性。如果没有明显的血小板或凝血异常,也不应放弃这一诊断途径,因为这种疾病可能会导致严重出血。
{"title":"Possible cause of abdominal internal oblique muscle hematoma induced by cough","authors":"Toshinori Nishizawa MD","doi":"10.1002/jgf2.672","DOIUrl":"10.1002/jgf2.672","url":null,"abstract":"<p>I have read with interest the article by Fujimori et al.<span><sup>1</sup></span> This case involves a 40-year-old male patient who presented with an abdominal internal oblique muscle hematoma. The intriguing aspect of this case is that the hematoma occurred following a coughing episode, despite the absence of coagulation abnormalities.</p><p>Given this unique presentation, it is important to explore all possible underlying factors that could contribute to such an event. One potential cause is the presence of acquired hemophilia, specifically hemorrhagic acquired factor XIII deficiency.<span><sup>2</sup></span> While the patient's platelet count and routine coagulation parameters might appear normal, it is crucial to emphasize that the absence of overt platelet or coagulation abnormalities does not definitively rule out the possibility of acquired factor XIII deficiency.</p><p>Acquired factor XIII deficiency is a relatively common disease, but most cases are asymptomatic and do not lead to severe bleeding. However, symptomatic acquired factor XIII deficiency, presenting with hemorrhagic symptoms, is exceedingly rare. This condition can be classified into autoimmune, nonautoimmune, and idiopathic types. Autoimmune acquired factor XIII deficiency is infrequent, with the majority of hemorrhagic acquired factor XIII deficiency being nonautoimmune. Nonautoimmune hemorrhagic acquired factor XIII deficiency, typically presenting as a less severe bleeding disorder, is often attributed to overconsumption or reduced biosynthesis. This can be triggered by various conditions, including disseminated intravascular coagulation, major surgical procedures, liver diseases, and other related disorders. In cases where acquired factor XIII deficiency is suspected, referral to a hematologist is advised, accompanied by a thorough investigation for any underlying pathologies.<span><sup>2</sup></span></p><p>Since neither prolonged clotting times nor decreased platelet counts are seen, many cases with unexplained intramuscular and subcutaneous bleeding might be overlooked. However, depending on the site and the amount of bleeding, the bleeding can be fatal, so prompt diagnosis and appropriate treatment are essential. Clinicians should be alert for acquired factor XIII deficiency when seeing such patients and consider measuring the factor XIII activity.</p><p>In conclusion, I recommend further investigation into the possibility of acquired factor XIII deficiency in cases similar to the one described. The absence of overt platelet or coagulation abnormalities should not discourage the pursuit of this diagnostic avenue, as this disorder can present with severe bleeding.</p><p>The author declares no conflicts of interest for this article.</p><p>This work has never been presented.</p>","PeriodicalId":51861,"journal":{"name":"Journal of General and Family Medicine","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jgf2.672","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138995191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of General and Family Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1